566169-96-8

Basic information

• Product Name: 6-BROMO-2-(4-NITROPHENYL)BENZOTHIAZOLE
• Synonyms: 6-BROMO-2-(4-NITROPHENYL)BENZOTHIAZOLE
• CAS NO: 566169-96-8
• Molecular Formula: C₁₃H₇BrN₂O₂S
• Molecular Weight: 335.17588
• Mol File: 566169-96-8.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-BROMO-2-(4-NITROPHENYL)BENZOTHIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2-(4-NITROPHENYL)BENZOTHIAZOLE(566169-96-8)
• EPA Substance Registry System: 6-BROMO-2-(4-NITROPHENYL)BENZOTHIAZOLE(566169-96-8)

Safety Data

• Hazardous Substances Data: 566169-96-8(Hazardous Substances Data)

Upstream product

• 182499-80-5 2,2′-disulfanediylbis(4-bromoaniline) 
• 555-16-8 4-nitrobenzaldehdye 
• 122-04-3 4-nitro-benzoyl chloride 
• 106-40-1 4-bromo-aniline 
• 15864-32-1 2-amino-6-bromobenzothiazole 
• 23451-95-8 2-amino-5-bromobenzenethiol 
• 566169-95-7 N-(4'-bromophenyl)-4-nitrothiobenzamide 
• 59280-03-4 N-(4'-bromophenyl)-4-nitrobenzamide 

Downstream Products

• 566169-97-9 2-(4’-aminophenyl)-6-bromobenzothiazole 
• 1226795-30-7 2-(4'-nitrophenyl)-6-tributylstannylbenzothiazole 
• 1226795-25-0 (2-(4-nitrophenyl)benzothiazol-6-yl)(phenyl)iodonium tosylate 
• 1226795-17-0 2-(4'-aminophenyl)-6-⁽¹⁸⁾F-fluorobenzothiazole 
• 1226795-31-8 2-(4'-N-tert-butyloxycarbonyl-methylaminophenyl)-6-bromobenzothiazole 
• 566169-98-0 2-(4'-methylaminophenyl)-6-bromobenzothiazole 

Relevant articles and documents

Development of a radioiodinated thioflavin-T-Congo-red hybrid probe for diagnosis of systemic amyloidosis

Introduction: Systemic amyloidosis is a group of diseases characterized by the deposition of amyloid protein in multiple organs throughout the body and causing their dysfunction. As amyloid deposition is observed at an early phase and is highly specific t

Compound for preparing compound specifically bound with beta amyloid protein, preparation method and application thereof

The invention discloses a compound on one hand, wherein the compound has a structure as shown in structural formula A as shown in the specification, and a substituent group R1 can be -NO2, and also can be -NH2; and the invention discloses application of t

COMPOUND FOR SPECIFICALLY BINDING TO AMYLOID ?-PROTEIN

Provided is a compound for specifically binding to amyloid β-protein. The compound has thereon a nuclide with a large thermal neutron capture cross section and the compound is capable of specifically binding to the amyloid β-protein. The property of the compound allows it to be used in conjunction with a neutron capture therapy device to eliminate amyloid β-protein. Similarly, when the compound is labelled with radioactive element 11C, the compound can also be used in conjunction with PET/CT for determining the part of the brain where amyloid β-protein is deposited, for diagnosing Alzheimer's disease. Also disclosed is a preparation process for the compound. The beneficial effect of the present disclosure is to make the therapy and diagnosis of Alzheimer's disease more targeted by providing the compound for specifically binding to amyloid β-protein.